AI in Antibody Discovery Market Size, Share and Trends Analysis 2025 to 2034
Segmentation of AI in Antibody Discovery Market:
AI in Antibody Discovery Market by Solution -
- AI Software Platforms
- On-Premise AI Tools
- Cloud-Based Solutions
- Consulting & Integration Services
AI in Antibody Discovery Market by Technology -
- Structure Prediction
- Affinity Maturation & Optimization
- De Novo Antibody Design
- Epitope/Paratope Prediction
- Others
AI in Antibody Discovery Market by Application-
- Target Identification
- Lead Optimization
- Lead Antibody Discovery
- Others
AI in Antibody Discovery Market by End-user-
- Pharmaceutical, Biotechnology, and Platform Developing Companies
- Academic & Research Institutes
- Contract Research Organizations (CROs)
- Others
AI in Antibody Discovery Market-By Region
- North America-
- The US
- Canada
- Europe-
- Germany
- The UK
- France
- Italy
- Spain
- Rest of Europe
- Asia-Pacific-
- China
- Japan
- India
- South Korea
- South East Asia
- Rest of Asia Pacific
- Latin America-
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Middle East & Africa-
- GCC Countries
- South Africa
- Rest of Middle East and Africa
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global AI in Antibody Discovery MarketSnapshot
Chapter 4. Global AI in Antibody Discovery MarketVariables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2025-2034
4.8. Global AI in Antibody Discovery MarketPenetration & Growth Prospect Mapping (US$ Mn), 2024-2034
4.9. Competitive Landscape & Market Share Analysis, By Key Player (2024)
4.10. Use/impact of AI on Global AI IN Antibody Discovery Industry Trends
Chapter 5. Global AI in Antibody Discovery Market Segmentation 1: By Technology, Estimates & Trend Analysis
5.1. Market Share By Technology, 2024 & 2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Technology:
5.2.1. Structure Prediction
5.2.2. Epitope/Paratope Prediction
5.2.3. De Novo Antibody Design
5.2.4. Affinity Maturation & Optimization
5.2.5. Other
Chapter 6. Global AI in Antibody Discovery MarketSegmentation 2: By Solution, Estimates & Trend Analysis
6.1. Market Share By Solution, 2024 & 2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Solution:
6.2.1. AI Software Platforms
6.2.2. Cloud-Based Solutions
6.2.3. On-Premise AI Tools
6.2.4. Consulting & Integration Services
Chapter 7. Global AI in Antibody Discovery MarketSegmentation 3: By Application, Estimates & Trend Analysis
7.1. Market Share By Application, 2024 & 2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Application:
7.2.1. Target Identification
7.2.2. Lead Antibody Discovery
7.2.3. Lead Optimization
7.2.4. Others
Chapter 8. Global AI in Antibody Discovery MarketSegmentation 4: By End User, Estimates & Trend Analysis
8.1. Market Share By End User, 2024 & 2034
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following End-User:
8.2.1. Contract Research Organizations (CROs)
8.2.2. Academic & Research Institutes
8.2.3. Others
Chapter 9. Global AI in Antibody Discovery MarketSegmentation 5: Regional Estimates & Trend Analysis
9.1. Global Scoop Stretcher Market, Regional Snapshot 2024 & 2034
9.2. North America
9.2.1. North America AI in Antibody Discovery MarketRevenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.2.1.1. US
9.2.1.2. Canada
9.2.2. North America AI in Antibody Discovery MarketRevenue (US$ Million) Estimates and Forecasts By Technology, 2021-2034
9.2.3. North America AI in Antibody Discovery MarketRevenue (US$ Million) Estimates and Forecasts By Application, 2021-2034
9.2.4. North America AI in Antibody Discovery MarketRevenue (US$ Million) Estimates and Forecasts By Solution, 2021-2034
9.2.5. North America AI in Antibody Discovery MarketRevenue (US$ Million) Estimates and Forecasts By End User, 2021-2034
9.3. Europe
9.3.1. Europe AI in Antibody Discovery MarketRevenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.3.1.1. Germany
9.3.1.2. U.K.
9.3.1.3. France
9.3.1.4. Italy
9.3.1.5. Spain
9.3.1.6. Rest of Europe
9.3.2. Europe AI in Antibody Discovery MarketRevenue (US$ Million) Estimates and Forecasts By Technology, 2021-2034
9.3.3. Europe AI in Antibody Discovery MarketRevenue (US$ Million) Estimates and Forecasts By Application, 2021-2034
9.3.4. Europe AI in Antibody Discovery MarketRevenue (US$ Million) Estimates and Forecasts By Solution, 2021-2034
9.3.5. Europe AI in Antibody Discovery MarketRevenue (US$ Million) Estimates and Forecasts By End User, 2021-2034
9.4. Asia Pacific
9.4.1. Asia Pacific AI in Antibody Discovery MarketRevenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.4.1.1. India
9.4.1.2. China
9.4.1.3. Japan
9.4.1.4. Australia
9.4.1.5. South Korea
9.4.1.6. Hong Kong
9.4.1.7. Southeast Asia
9.4.1.8. Rest of Asia Pacific
9.4.2. Asia Pacific AI in Antibody Discovery MarketRevenue (US$ Million) Estimates and Forecasts By Technology, 2021-2034
9.4.3. Asia Pacific AI in Antibody Discovery MarketRevenue (US$ Million) Estimates and Forecasts By Application, 2021-2034
9.4.4. Asia Pacific AI in Antibody Discovery MarketRevenue (US$ Million) Estimates and Forecasts By Solution, 2021-2034
9.4.5. Asia Pacific AI in Antibody Discovery MarketRevenue (US$ Million) Estimates and Forecasts By End User, 2021-2034
9.5. Latin America
9.5.1. Latin America AI in Antibody Discovery MarketRevenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.5.1.1. Brazil
9.5.1.2. Mexico
9.5.1.3. Rest of Latin America
9.5.2. Latin America AI in Antibody Discovery MarketRevenue (US$ Million) Estimates and Forecasts By Technology, 2021-2034
9.5.3. Latin America AI in Antibody Discovery MarketRevenue (US$ Million) Estimates and Forecasts By Application, 2021-2034
9.5.4. Latin America AI in Antibody Discovery MarketRevenue (US$ Million) Estimates and Forecasts By Solution, 2021-2034
9.5.5. Latin America AI in Antibody Discovery MarketRevenue (US$ Million) Estimates and Forecasts By End User, 2021-2034
9.6. Middle East & Africa
9.6.1. Middle East & Africa AI in Antibody Discovery MarketRevenue (US$ Million) Estimates and Forecasts by country, 2021-2034
9.6.1.1. GCC Countries
9.6.1.2. Israel
9.6.1.3. South Africa
9.6.1.4. Rest of Middle East and Africa
9.6.2. Middle East & Africa AI in Antibody Discovery MarketRevenue (US$ Million) Estimates and Forecasts By Technology, 2021-2034
9.6.3. Middle East & Africa AI in Antibody Discovery MarketRevenue (US$ Million) Estimates and Forecasts By Application, 2021-2034
9.6.4. Middle East & Africa AI in Antibody Discovery MarketRevenue (US$ Million) Estimates and Forecasts By Solution, 2021-2034
9.6.5. Middle East & Africa AI in Antibody Discovery MarketRevenue (US$ Million) Estimates and Forecasts By End User, 2021-2034
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. LabGenius Therapeutic
10.2.1.1. Business Overview
10.2.1.2. Key Product/Service
10.2.1.3. Financial Performance
10.2.1.4. Geographical Presence
10.2.1.5. Recent Developments with Business Strategy
10.2.2. BigHat Biosciences, Inc.
10.2.3. Generate Biomedicines, Inc.
10.2.4. InveniAI LLC
10.2.5. Antiverse
10.2.6. EVQLV Inc.
10.2.7. Chai Discovery Inc.
10.2.8. MAbSilico
10.2.9. Cradle Bio B.V.
10.2.10. Alloy Therapeutics, Inc.
Research Design and Approach
This study employed a multi-step, mixed-method research approach that integrates:
- Secondary research
- Primary research
- Data triangulation
- Hybrid top-down and bottom-up modelling
- Forecasting and scenario analysis
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary Research
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Sources Consulted
Secondary data for the market study was gathered from multiple credible sources, including:
- Government databases, regulatory bodies, and public institutions
- International organizations (WHO, OECD, IMF, World Bank, etc.)
- Commercial and paid databases
- Industry associations, trade publications, and technical journals
- Company annual reports, investor presentations, press releases, and SEC filings
- Academic research papers, patents, and scientific literature
- Previous market research publications and syndicated reports
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary Research
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Stakeholders Interviewed
Primary interviews for this study involved:
- Manufacturers and suppliers in the market value chain
- Distributors, channel partners, and integrators
- End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
- Industry experts, technology specialists, consultants, and regulatory professionals
- Senior executives (CEOs, CTOs, VPs, Directors) and product managers
Interview Process
Interviews were conducted via:
- Structured and semi-structured questionnaires
- Telephonic and video interactions
- Email correspondences
- Expert consultation sessions
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
Data Processing, Normalization, and Validation
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
- Standardization of units (currency conversions, volume units, inflation adjustments)
- Cross-verification of data points across multiple secondary sources
- Normalization of inconsistent datasets
- Identification and resolution of data gaps
- Outlier detection and removal through algorithmic and manual checks
- Plausibility and coherence checks across segments and geographies
This ensured that the dataset used for modelling was clean, robust, and reliable.
Market Size Estimation and Data Triangulation
Bottom-Up Approach
The bottom-up approach involved aggregating segment-level data, such as:
- Company revenues
- Product-level sales
- Installed base/usage volumes
- Adoption and penetration rates
- Pricing analysis
This method was primarily used when detailed micro-level market data were available.
Top-Down Approach
The top-down approach used macro-level indicators:
- Parent market benchmarks
- Global/regional industry trends
- Economic indicators (GDP, demographics, spending patterns)
- Penetration and usage ratios
This approach was used for segments where granular data were limited or inconsistent.
Hybrid Triangulation Approach
To ensure accuracy, a triangulated hybrid model was used. This included:
- Reconciling top-down and bottom-up estimates
- Cross-checking revenues, volumes, and pricing assumptions
- Incorporating expert insights to validate segment splits and adoption rates
This multi-angle validation yielded the final market size.
Forecasting Framework and Scenario Modelling
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Forecasting Methods
- Time-series modelling
- S-curve and diffusion models (for emerging technologies)
- Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
- Price elasticity models
- Market maturity and lifecycle-based projections
Scenario Analysis
Given inherent uncertainties, three scenarios were constructed:
- Base-Case Scenario: Expected trajectory under current conditions
- Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
- Conservative Scenario: Slow adoption, regulatory delays, economic constraints
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.
Request Customization
Add countries, segments, company profiles, or extend forecast — free 10% customization with purchase.
Customize This Report →Enquire Before Buying
Speak with our analyst team about scope, methodology, pricing, or deliverable formats.
Enquire Now →Frequently Asked Questions
AI in Antibody Discovery Market Size is valued at USD 471.5 Mn in 2024 and is predicted to reach USD 3,011.7 Mn by the year 2034
AI in Antibody Discovery Market is expected to grow at a 22.9% CAGR during the forecast period for 2025 to 2034.
LabGenius Therapeutics, InveniAI LLC, Antiverse, Cradle Bio B.V., EVQLV Inc., BigHat Biosciences, Inc., Generate Biomedicines, Inc., Chai Discovery Inc., MAbSilico, and Alloy Therapeutics, Inc.
Solution, Technology, Application, End-user, and Region are the key segments of the AI in Antibody Discovery Market
North America region is leading the AI in Antibody Discovery Market.